NEW YORK (GenomeWeb News) – Theranostics Health said today that it is collaborating with Duke University on a research effort for new prevention and treatment options for breast cancer under a recent grant from the Susan G. Komen Foundation.

The Rockville, Md.-based firm said that it has been collaborating with Duke investigator Victoria Seewaldt for the past year. That research formed the "underlying rationale and preliminary data in support of the research proposed" to the Komen Foundation, which is now providing Duke with a Promise Grant.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.